PFlex R1 & R2 Respiratory Panels
Respiratory Infections (COVID-19, RSV, Influenza)
CommercialActive
Key Facts
Indication
Respiratory Infections (COVID-19, RSV, Influenza)
Phase
Commercial
Status
Active
Company
About Pharmozyme
Pharmozyme is a private, commercial-stage diagnostics company leveraging its proprietary enzyme purification technology to produce high-fidelity qPCR kits. Its product portfolio targets high-volume infectious disease testing markets with its UTI qPCR panel (PFlexU1), respiratory panels (PFlex R1/R2), and an extraction-free COVID-19 RT-PCR kit. The company differentiates itself by addressing reagent contamination—a known pain point in molecular diagnostics—to improve test accuracy and reliability for clinical and research labs. It operates under an ISO 13485:2016 quality management system, indicating a focus on regulated medical device manufacturing.
View full company profile